Trefny, M.P.* ; Kroemer, G.* ; Zitvogel, L.* & Kobold, S. Metabolites as agents and targets for cancer immunotherapy. Nat. Rev. Drug Discov., DOI: 10.1038/s41573-025-01227-z (2025)
Hadian, K. & Stockwell, B.R.* The therapeutic potential of targeting regulated non-apoptotic cell death. Nat. Rev. Drug Discov. 22, 723-742 (2023)
Müller, T.D. ; Blüher, M. ; Tschöp, M.H. & DiMarchi, R.D.* Anti-obesity drug discovery: Advances and challenges. Nat. Rev. Drug Discov. 21, 201-223 (2022)
Siehler, J. ; Blöchinger, A. ; Meier, M. & Lickert, H. Engineering islets from stem cells for advanced therapies of diabetes. Nat. Rev. Drug Discov. 20, 920–940 (2021)
Conrad, M. ; Friedmann Angeli, J.P.F. ; Vandenabeele, P.* & Stockwell, B.R.* Regulated necrosis: Disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 15, 348-366 (2016)
von Boehmer, H.* & Daniel, C. Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer. Nat. Rev. Drug Discov. 12, 51-63 (2013)